| Literature DB >> 25384624 |
Anita Bálint1, Klaudia Farkas, Pallagi-Kunstár Éva, Gabriella Terhes, Edit Urbán, Mónika Szucs, Tibor Nyári, Zsuzsanna Bata, Ferenc Nagy, Zoltán Szepes, Pál Miheller, Katalin Lorinczy, Péter László Lakatos, Barbara Lovász, Szamosi Tamás, Andrea Kulcsár, Anna Berényi, Dalma Törocsik, Tímea Daróczi, Zoltán Saródi, Tibor Wittmann, Tamás Molnár.
Abstract
OBJECTIVE: Influenza vaccination is recommended for inflammatory bowel disease (IBD) patients on immunosuppressive therapy. The objective was to evaluate the antibody and cell-mediated immune response to the split and whole virion influenza vaccine in patients with IBD treated with anti-TNF-α and immunosuppressive therapy. PATIENTS AND METHODS: One hundred and fifty-six immunocompromised IBD patients were vaccinated. Fifty-three patients (control group) refused vaccination. Split virion vaccine and whole virion vaccine were used. Serum samples were obtained for pre- and postimmunization antibody titers to influenza vaccine (A/California/7/2009 [H1N1], A/Victoria/361/2011 [H3N2], B/Wisconsin/1/2010-like B/Hubei-Wujiagang/158/2009). Cell-mediated response was evaluated using an interferon (INF)-γ, interleukine (IL)-2 and tumor necrosis factor (TNF)-α ELISA.Entities:
Keywords: anti-TNF therapy; cellular immune response; immunosuppression; inflammatory bowel diseases; influenza; vaccination
Mesh:
Substances:
Year: 2014 PMID: 25384624 DOI: 10.3109/00365521.2014.928902
Source DB: PubMed Journal: Scand J Gastroenterol ISSN: 0036-5521 Impact factor: 2.423